OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present at three events in November. The Company’s agenda is as follows:
BIO-Europe International Partnering Conference
Dr. Robert H. Pierce, Chief Scientific Officer, will present a corporate overview of the Company at the 20th Annual BIO Europe International Partnering Conference, taking place November 3-5, 2014 in Frankfurt, Germany.
Help employers find you! Check out all the jobs and post your resume.
